Search research articles
Contact Us
Filters
Showing results (591-600 of 688) with videos related to
Page
of 69
Sort By:
Journal of the American College of Cardiology
|
September 11, 2024
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF
Ankeet S Bhatt, Deepak L Bhatt, Ph Gabriel Steg, et al.
JACC. Heart Failure
|
June 24, 2026
Sleep Apnea in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial
Henri Lu, Sophia R Schneider, Maria A Pabón, et al.
JACC. Heart Failure
|
May 11, 2020
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials
Jonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Heart Failure Reviews
|
May 25, 2012
Soluble guanylate cyclase: a potential therapeutic target for heart failure
Mihai Gheorghiade, Catherine N Marti, Hani N Sabbah, et al.
JAMA Cardiology
|
March 30, 2025
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial
Akshay S Desai, Pardeep S Jhund, Muthiah Vaduganathan, et al.
European Journal of Heart Failure
|
March 12, 2026
Finerenone and Quality of Life in Heart Failure: Component-Level Analyses and Clinical Relevance of the Kansas City Cardiomyopathy Questionnaire
Yasuhiro Hamatani, Alexander Peikert, Brian L Claggett, et al.
JAMA Cardiology
|
August 13, 2025
Efficacy and Tolerability of Finerenone According to the Use and Dosage of Diuretics: A Prespecified Analysis of the FINEARTS-HF Randomized Clinical Trial
Misato Chimura, Pardeep S Jhund, Alasdair D Henderson, et al.
JACC. Advances
|
June 27, 2025
Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HF
Andrew J Sauer, Joycie Chang, Zhuxuan Fu, et al.
European Journal of Heart Failure
|
October 3, 2025
Interplay of serum potassium and kidney function with finerenone in heart failure with mildly reduced or preserved ejection fraction: Findings from FINEARTS-HF
João Pedro Ferreira, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation. Heart Failure
|
April 18, 2018
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial
Eldrin F Lewis, Brian Claggett, Amil M Shah, et al.
Page
of 69
Search research articles
Search
Showing results (591-600 of 688) with videos related to
Sort By:
Page
of 69
Journal of the American College of Cardiology
|
September 11, 2024
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF
Ankeet S Bhatt, Deepak L Bhatt, Ph Gabriel Steg, et al.
JACC. Heart Failure
|
June 24, 2026
Sleep Apnea in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial
Henri Lu, Sophia R Schneider, Maria A Pabón, et al.
JACC. Heart Failure
|
May 11, 2020
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials
Jonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Heart Failure Reviews
|
May 25, 2012
Soluble guanylate cyclase: a potential therapeutic target for heart failure
Mihai Gheorghiade, Catherine N Marti, Hani N Sabbah, et al.
JAMA Cardiology
|
March 30, 2025
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial
Akshay S Desai, Pardeep S Jhund, Muthiah Vaduganathan, et al.
European Journal of Heart Failure
|
March 12, 2026
Finerenone and Quality of Life in Heart Failure: Component-Level Analyses and Clinical Relevance of the Kansas City Cardiomyopathy Questionnaire
Yasuhiro Hamatani, Alexander Peikert, Brian L Claggett, et al.
JAMA Cardiology
|
August 13, 2025
Efficacy and Tolerability of Finerenone According to the Use and Dosage of Diuretics: A Prespecified Analysis of the FINEARTS-HF Randomized Clinical Trial
Misato Chimura, Pardeep S Jhund, Alasdair D Henderson, et al.
JACC. Advances
|
June 27, 2025
Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HF
Andrew J Sauer, Joycie Chang, Zhuxuan Fu, et al.
European Journal of Heart Failure
|
October 3, 2025
Interplay of serum potassium and kidney function with finerenone in heart failure with mildly reduced or preserved ejection fraction: Findings from FINEARTS-HF
João Pedro Ferreira, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation. Heart Failure
|
April 18, 2018
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial
Eldrin F Lewis, Brian Claggett, Amil M Shah, et al.
Page
of 69